apararenone   Click here for help

GtoPdb Ligand ID: 12039

Synonyms: compound 39 [PMID: 35652647] | MT-3995 | MT3995
Compound class: Synthetic organic
Comment: Apararenone (MT-3995) is a selective and potent non-steroidal mineralocorticoid receptor (MR) antagonist [1]. It was developed to counteract MR-induced hypertension and organ damage in diseases including diabetic nephropathy and NASH.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 84.09
Molecular weight 364.09
XLogP 2.4
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1ccc(cc1)N1c2ccc(cc2OC(C1=O)(C)C)NS(=O)(=O)C
Isomeric SMILES O=C1C(C)(C)Oc2cc(NS(=O)(=O)C)ccc2N1c1ccc(F)cc1
InChI InChI=1S/C17H17FN2O4S/c1-17(2)16(21)20(13-7-4-11(18)5-8-13)14-9-6-12(10-15(14)24-17)19-25(3,22)23/h4-10,19H,1-3H3
InChI Key AZNHWXAFPBYFGH-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Apararenone (MT-3995) is a phase 2 clinical candidate.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02517320 Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy Phase 2 Interventional Mitsubishi Tanabe Pharma Corporation 2
NCT02923154 Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) Phase 2 Interventional Mitsubishi Tanabe Pharma Corporation